期刊文献+

IL-17和IL-23在成人原发性肾病综合征患者中的变化及意义 被引量:7

The variation and significance of IL-17 and IL-23 in adult patients with primary nephrotic syndrome
下载PDF
导出
摘要 目的观察白细胞介素17(IL-17)和白细胞介素23(IL-23)在成人原发性肾病综合征(PNS)中的变化,探讨其在PNS发生及发展中的作用及临床意义。方法选取初次就诊并激素治疗有效的PNS住院患者35例(实验组),按常规剂量给予强的松治疗;选取同期健康体检者20名作为对照组。检测对照组、PNS患者治疗前和完全缓解时的外周血T细胞亚群及血清和24 h尿液中IL-17、IL-23、白细胞介素6(IL-6)水平,并分别与24 h尿蛋白定量进行相关分析。结果与对照组相比,PNS患者外周血CD3+、CD3+CD4+细胞数减少(P<0.05),血清IL-17、IL-6和24 h尿液中IL-17、IL-23、IL-6水平明显增加(P<0.05);经治疗,PNS患者CD3+、CD3+CD4+细胞数较治疗前明显增加(P<0.05),24 h尿液中IL-17、IL-23、IL-6水平较治疗前明显降低(P<0.05)。PNS患者血清IL-17、IL-23水平和24 h尿液IL-17、IL-23水平均与24 h尿蛋白定量呈显著正相关(P均<0.01)。结论 IL-17和IL-23可能与PNS患者大量蛋白尿的形成有关;激素治疗能够显著改善PNS患者细胞免疫功能紊乱和T细胞亚群失衡;监测PNS患者血清和24 h尿液中IL-17和IL-23的水平,可能有助于病情的判断和指导临床治疗。 Objective To investigate the changes of interleukin 17( IL-17) and interleukin 23( IL-23) in adult patients with primary nephrotic syndrome( PNS) and their roles and clinical significance of IL-17 and IL-23 variations in the occurrence and development of PNS. Methods A total of 35 steroid-effective hospitalized patients with PNS and 20 healthy subjects( healthy control group) were enrolled in the study. The patients with PNS were treated with prednisone according to the conventional dose. T cell subsets from peripheral blood and the levels of IL-17,IL-23 and IL-6 from serum and 24 h urine were detected in healthy control group and the patients with PNS before and after treatment. The correlations of 24 h urinary protein quantification with T cell subsets in peripheral blood and the levels of IL-17,IL-23 and IL-6 in both serum and 24 h urine were analyzed,respectively. Results Compared with healthy control group,the percentage of CD3^+or CD3^+CD4^+cells from patients with PNS significantly decreased( P〈0. 05),and the levels of IL-17 and IL-6 from serum as well as IL-17,IL-23 and IL-6 from 24 h urine significantly increased( P〈0. 05). After treatment,the percentage of CD3+or CD3+CD4+cells significantly increased( P〈0. 05),and the levels of IL-17,IL-23 and IL-6 in 24 h urine significantly decreased( P〈0. 05). There were positive correlations between 24 h urinary protein quantification and the levels of IL-17 and IL-23 in both serum and 24 h urine respectively( P〈0. 01).Conclusions IL-17 and IL-23 may contribute to the proteinuria of PNS. Hormone therapy can improve the disorder of cell immune function and the imbalance of T cell subsets. Monitoring the levels of IL-17 and IL-23 in serum and 24 h urine may be helpful for disease judgement and clinical therapy.
出处 《检验医学》 CAS 2015年第6期554-558,共5页 Laboratory Medicine
基金 上海市闵行区科委自然基金资助项目(2010MHZ027) 复旦大学985医院优势学科资助项目(复医科办字[2012]1号)
关键词 白细胞介素17 白细胞介素23 白细胞介素6 T细胞亚群 24H尿蛋白定量 原发性肾病综合征 Interleukin 17 Interleukin 23 Interleukin 6 T cell subset 24 h urinary protein quantification Primary nephrotic syndrome
  • 相关文献

参考文献19

  • 1王波,刘志红,吴燕,左科,黄倩,秦卫松,曾彩虹,黎磊石.特发性膜性肾病患者调节性T细胞和B淋巴细胞的变化及其临床意义[J].肾脏病与透析肾移植杂志,2009,18(4):322-328. 被引量:17
  • 2HARRINGTON LE, HATI'ON RD, MANGAN PR, et al. Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages [ J ]. Nat Immunol, 2005,6 ( 11 ) : 1123-1132.
  • 3MIYAMOTO M, PRAUSE O, SJOSTRAND M, et al. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways [ J ]. I Immuno1,2003,170 ( 9 ):4665-4672.
  • 4KORN T, OUKKA M, KUCHROO V, et al. Thl7 cells: effector T cells with inflammatory properties [ J ]. Semin Immunol,2007,19 (6) :362 - 371.
  • 5VELDHOEN M, HOCKING R J, ATKINS C J, et al. TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17- producing T cells [ J ]. Immunity, 2006,24 ( 2 ) : 179- 189.
  • 6HOEVE MA, SAVAGE ND, DE BOER T, et al. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells [ J]. Eur J Immunol, 2006,36(3 ) :661-670.
  • 7VOLPE E, SERVANT N, ZOLLINGER R, et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory eytokines in driving and modulating human T ( H ) -17 responses [J]. Nat Immunol,2008,9(6):650-657.
  • 8陆再英,钟南山主编.内科学[M].北京:人民卫生出版社,2010:513-525.
  • 9丁楠,郝丽,黎淮,王瑞峰.原发性肾病综合征患者免疫指标变化的临床意义探讨[J].中国免疫学杂志,2011,27(4):356-359. 被引量:32
  • 10彭小梅,叶琨,熊礼佳,曾金盛,韦俏宇,蓝娇.激素敏感型原发性肾病综合征患者外周血T淋巴细胞亚群及调节性T淋巴细胞的变化及意义[J].中国临床新医学,2013,6(7):624-628. 被引量:2

二级参考文献37

  • 1黄建亭.单纯性肾病综合征患儿T淋巴细胞亚群及体液免疫变化[J].实用儿科临床杂志,2005,20(1):53-54. 被引量:10
  • 2Ponticelli C, Passerini P. Membranous glomerulonephritis. In:Massry SG, Glassock R J, et al. Massry & Glassockps Textbook of Nephrology. 4th ed. Philadelphia: Lippineott Williams Wilkins, 2001,707 -713.
  • 3Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13, 519 renal biopsies. Kidney Int, 2004, 66 (3) : 920 - 923.
  • 4Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N EnglJ Med, 2009,361 ( 1 ) : 11 - 21.
  • 5Ruggenenti P, Chiurchiu C, Brusegan V, et al. Rituximab in idiopathic membranous nephropathy: a one-year prospective study. J Am Soe Nephrol, 2003, 14(7) : 1851 -1857.
  • 6Kuroki A, Iyoda M, Shibata T, et al. Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephrop athy. Kindnet Int, 2005, 68 : 302 - 310.
  • 7Cohen CD, Calvaresi N, Armelloni S, et al. CD20-positive infiltrates in human membranous glomerulonephritis. J Nephrol, 2005, 18: 328 - 333.
  • 8Fontenot J, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4^+ CD25^+ regulatory T cells. Nat Immunol, 2003, 4(4) : 330 -336.
  • 9Jonuleit H, Schmitt E, Kakirman H, et al. Infectious tolerance: human CD25^ + regulatory T cells convey suppressor activity to conventional CD4^ + T helper cells. J Exp Med, 2002, 196 (2) : 255 - 260.
  • 10Kukreja A, Cost G, Marker J, et al. Multiple immuno-regulatory defect s in type-1 diabetes. J Clin Invest, 2002, 109 (1) :131 -140.

共引文献207

同被引文献64

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部